ArticleScientific reports2025
Morphology-driven photothermal performance of polymer-functionalized mos₂ nanoplatforms for targeted therapeutic applications.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Highly sensitive electrochemical immunosensor for alpha-fetoprotein detection based on trimetallic metal-organic framework nanozymes with peroxidase-like activity.Mikrochimica acta · 2026Article
- Advanced Design Concepts for Shape-Memory Polymers in Biomedical Applications and Soft Robotics.Polymers · 2026Review
- Intravoxel Incoherent Motion Diffusion-weighted MR Imaging for Monitoring the Therapeutic Efficacy of Interventional Photothermal Therapy with Nanoparticles in Rabbit VX2 TumorsCurrent medical imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we report the synthesis and photothermal evaluation of polymer-functionalized molybdenum disulfide (MoS₂) nanoplatforms with distinct morphologies; three-dimensional (3D) nanoflowers (MNF) and two-dimensional (2D) nanorods (MNR), tailored for targeted drug delivery applications. The MoS₂ nanostructures were synthesized via a hydrothermal route by modulating the sulfur precursor, yielding morphology-dependent growth. The resulting nanostructures were subsequently functionalized with polyethylene glycol (PEG) and polyethyleneimine (PEI), producing MNF@PEG@PEI (MFPP) and MNR@PEG@PEI (MRPP) platforms. Comprehensive characterization via FESEM, FTIR, and XRD confirmed the formation of distinct morphologies, effective polymer functionalization through amine and carboxyl groups, and the coexistence of 1T/2H MoS₂ phases. Photothermal properties were evaluated under 808 nm NIR laser irradiation. MFPP demonstrated a photothermal conversion efficiency of 46.86%, significantly higher than the 19.94% observed for MRPP. Moreover, functionalization enhanced the temperature elevation in MNF from 10.2 °C to 14.5 °C, whereas MNR showed minimal improvement (5.0 °C to 5.6 °C). This performance enhancement in MFPP is attributed to its porous, multi-layered architecture, which facilitates higher NIR absorption via multiple internal reflections and active defect sites. These findings highlight MFPP as a promising candidate for photothermal and photoacoustic imaging-guided drug delivery, reinforcing the importance of morphological and surface-engineering strategies in designing next-generation MoS₂-based nanocarriers for cancer therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.